
Bioorganic and Medicinal Chemistry Letters p. 919 - 924 (1998)
Update date:2022-08-05
Topics:
Eda, Masahiro
Ashimori, Atsuyuki
Akahoshi, Fumihiko
Yoshimura, Takuya
Inoue, Yoshihisa
Fukaya, Chikara
Nakajima, Masahide
Fukuyama, Hajime
Imada, Teruaki
Nakamura, Norifumi
Appropriate structural modification of the difluoromethylene ketone derivatives at both P3 and P' positions led us to the discovery of peptidyl human heart chymase inhibitor 12h which shows potent activity with Ki = 6 nM and high selectivity against closely related serine protease bovine a- chymotrypsin (chymotrypsin Ki = >100 μM). Using the compound 12b, a docking study with human heart chymase was carded out to presume probable interactions.
View MoreContact:+86-519-8525-2752
Address:Changzhou
Jiangsu Taihu New Materials Holding Co., Ltd
Contact:+86-519-86160108
Address:Xueyan Town, Changzhou City, Jiangsu Province, 213169, China
Weifang Arylchem Chemical Co., LTD
Contact:86-536-5217866
Address:Development Zone, Shouguang, Shandong Province
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
Ningbo Inno Pharmchem Co., Ltd.
Contact:86-574-87319282
Address:6F-5,NO.163 RUIQING RD.,NINGBO 315000 CHINA
Doi:10.1016/S0040-4039(98)00610-8
(1998)Doi:10.1246/bcsj.71.1221
(1998)Doi:10.1039/a801714j
(1998)Doi:10.1016/S0040-4039(98)00619-4
(1998)Doi:10.1016/0022-328X(92)83254-F
(1992)Doi:10.1021/acs.jmedchem.7b00468
(2017)